Sociedad Quimica y Minera S.A. Common Stock vs Stryker Corporation — how do they compare? Sociedad Quimica y Minera S.A. Common Stock trades at $64.19 (market cap $18.43B), while Stryker Corporation trades at $280.41 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 5.8× Sociedad Quimica y Minera S.A. Common Stock's market cap, and Sociedad Quimica y Minera S.A. Common Stock pays the higher dividend (3.76%). Which is the better fit depends on your goals — on Pluang, investors hold Sociedad Quimica y Minera S.A. Common Stock for 0 Days and Stryker Corporation for 20 Days on average.
| SQM | SYK | |
|---|---|---|
Market Cap | $18.43B | $106.24B |
Volume | 710,989 | 2,982,001 |
Sector | Basic Materials | Health |
52-Week High | $95.31 | $388.35 |
52-Week Low | $40.77 | $269.75 |
Typical Hold Time | 0 Days | 20 Days |
Enterprise Value | $19.29B | $117.70B |
Dividend Yield | 3.76% | 1.27% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Stryker Corporation (SYK) trades at $275.40, down 1.11% amid bearish technical signals and recent negative news regarding manufacturing issues. The company maintains strong fundamentals with Q2 2026 EPS beating expectations at $3.69 versus $3.49 expected, and profitability metrics remain robust with a 14.43% net income margin. Analyst consensus remains overwhelmingly bullish with a $368.11 price target representing 33% upside potential.
Despite near-term headwinds from manufacturing disclosures and legal investigations, Stryker's solid earnings track record, strong cash flow generation, and dominant medical technology position support long-term growth prospects. Key risks include ongoing legal scrutiny and competitive pressures in the medtech sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SQM is a mining and chemical company operating in northern Chile. Its businesses include lithium, iodine, specialty plant nutrition, potassium, solar salts, and industrial chemicals.
Read more on SQM →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →